Dr. Steven K. Libutti Named Inaugural William N. Hait Director at Rutgers Cancer Institute



The Rutgers Board of Governors appointed Steven K. Libutti, MD, FACS, as the inaugural William N. Hait Director of Rutgers Cancer Institute. The endowed directorship was established through the donation of $7.4 million raised to honor the pioneering contributions to cancer research and care by William (Bill) N. Hait, MD, PhD.

 

Results: Study on Advanced-Stage Hodgkin Lymphoma Published in the New England Journal of Medicine

Groundbreaking results were published from a clinical trial evaluating a novel treatment for advanced-stage classic Hodgkin lymphoma. Co-authored by Andrew M. Evens, DO, MBA, MSc, Deputy Director of Clinical Services, the study introduces a practice-changing approach that integrates checkpoint immunotherapy into the frontline treatment of adolescent and adult Hodgkin lymphoma patients.

Partners Celebrate Milestone in Development of the Vogel Medical Campus at Tinton Falls

Monmouth Medical Center, an RWJBarnabas Health facility, raised the final beam at the

Specialty and Cancer Care Pavilion at the Vogel Medical Campus last month.

In partnership with Rutgers Cancer

Institute this facility will bring state-of-the-art comprehensive cancer care close to home for the residents of Monmouth County.

Nipple-Sparing Mastectomy: A Modern Approach to Breast Cancer Surgery

Thanks to advances in breast cancer research and personalized treatment approaches, breast cancer patients now have more surgical options. Among these innovative approaches is the Nipple-Sparing Mastectomy (NSM) - a procedure that not only removes the cancerous tissue but also preserves the nipple and much of the breast’s natural appearance.